Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Company Update

6 Mar 2020 07:27

RNS Number : 2591F
Cineworld Group plc
06 March 2020
 

 

Cineworld Group plc ("Cineworld")

 

Company Update

 

 

Given the impact that COVID-19 is having on the broader markets, we feel it is important to update our shareholders on current trading. Thus far, we have not observed any material impact on our movie theatre admissions due to COVID-19. Following an increase in admissions in the first two months of the year against the same period in the previous year, we continue to see good levels of admissions in all our territories, despite the reported spread of COVID-19. Although the release of the new Bond movie has been postponed to November 2020 largely due to closure of cinemas in the Asian markets, the studios have advised us that in the countries in which we operate, they currently remain committed to their release schedule for the coming months and remainder of the year.

 

There can be no certainty as to the future impact of COVID-19. We are however taking measures to ensure that we prepare our business for all possible eventualities. Should conditions relating to COVID-19 continue or worsen, we have measures at our disposal to reduce the impact on our business including, but not limited to, capex postponement and cost reduction.

 

We today release the following key unaudited financial information for the year ending 31 December 2019 ahead of the release of our audited results for that period on 12 March 2020. We do not expect any material deviation from the unaudited figures once the audit is complete.

 

Key Financial Highlights (IAS 17):

Revenue: $4,369m

Adjusted EBITDA(1): $1,032m

Net Debt (excluding lease liabilities)(1): $3,479m

 

(1)Adjusted EBITDA and Net Debt are presented on a comparable basis with the Group's 2018 published results, before the impact of the new lease accounting standard.

 

 

Cautionary note concerning forward looking statements

Certain statements in this announcement are forward looking and so involve risk and uncertainty because they relate to events, and depend upon circumstances that will occur in the future and therefore results and developments can differ materially from those anticipated. The forward looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

Enquiries: Cineworld Group plc

Israel Greidinger

Nisan Cohen

Manuela Van Dessel

 

8th Floor, Vantage London

Great West Road

Brentford

TW8 9AG

investors@cineworld.co.uk

James Leviton

Andy Parnis

Rob Allen

 

+44 (0)20 7251 3801

cineworld-lon@finsbury.com

 

 

 

 

LEI: 213800J2J3TOOI176M73

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFIFLDVTIRIII
Date   Source Headline
15th Apr 20205:05 pmRNSHolding(s) in Company
15th Apr 20204:52 pmRNSLong Term Incentive Plan Awards
14th Apr 20201:01 pmRNSHolding(s) in Company
9th Apr 20204:23 pmRNSChange in Director’s Details
9th Apr 20209:24 amRNSHolding(s) in Company
8th Apr 20205:10 pmRNSAnnual Report and Notice of Annual General Meeting
7th Apr 20207:00 amRNSCOVID-19 Update and Suspension of Dividend
2nd Apr 20205:31 pmRNSHolding(s) in Company
1st Apr 20201:58 pmRNSHolding(s) in Company
23rd Mar 20205:55 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 202012:34 pmRNSHolding(s) in Company
23rd Mar 202012:33 pmRNSHolding(s) in Company
23rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20205:46 pmRNSHolding(s) in Company
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
18th Mar 20204:59 pmRNSDirector/PDMR Shareholding
16th Mar 20204:07 pmRNSHolding(s) in Company
16th Mar 20209:48 amRNSDirectorate Change
13th Mar 20204:40 pmRNSSecond Price Monitoring Extn
13th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20201:28 pmRNSHolding(s) in Company
12th Mar 202012:08 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20207:30 amRNSDean Moore Dignity plc appointment
12th Mar 20207:00 amRNSPreliminary Results 2019
9th Mar 20207:16 amRNSMajor shareholder to refinance margin loan
6th Mar 20207:27 amRNSCompany Update
4th Mar 20205:15 pmRNSHolding(s) in Company
4th Mar 20205:13 pmRNSHolding(s) in Company
11th Feb 20203:51 pmRNSResults of General Meeting
6th Feb 20203:33 pmRNSDirector/PDMR Shareholding
4th Feb 202012:46 pmRNSHolding(s) in Company
28th Jan 20204:48 pmRNSHelen Weir Greencore Group plc appointment
24th Jan 20203:18 pmRNSPublication of Class 1 Circular
21st Jan 20202:23 pmRNSHolding(s) in Company
17th Jan 20202:39 pmRNSHolding(s) in Company
17th Jan 20202:10 pmRNSDirector/PDMR Shareholding
24th Dec 201910:22 amRNSDirector/PDMR Shareholding
20th Dec 20195:43 pmRNSInterim Dividend - Exchange Rate
19th Dec 20192:59 pmRNSDirector/PDMR Shareholding
18th Dec 20191:52 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSProposed C$2.8bn/US$2.1bn acquisition of Cineplex
3rd Dec 20197:00 amRNSTrading Statement
19th Nov 20193:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.